Distinct mechanisms of cell in breast cancer and their clinical implication

Aodi Li1, Sishi Liu2, Ying Xuan3

  • 1Department of Medical Oncology, The First Hospital of China Medical University, Shenyang, Liaoning Province, China.

PubMed

Insights

This review explores cell death pathways in breast cancer, highlighting their role in tumor progression. Understanding these mechanisms offers new therapeutic targets for breast cancer treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cellular Biology

Background:

  • Breast cancer is a globally prevalent, heterogeneous disease with significant morbidity.
  • Despite therapeutic advances, novel targets are crucial due to molecular diversity and treatment complexity.
  • Hallmarks of cancer include suppressed cell death, necessitating exploration of various cell death modalities.

Purpose of the Study:

  • To systematically review the molecular mechanisms of diverse cell death pathways in breast cancer.
  • To identify novel therapeutic targets and strategies based on cell death modulation.
  • To provide insights for improved clinical management of breast cancer.

Main Methods:

  • Systematic literature review of cell death pathways in breast cancer.
  • Analysis of molecular underpinnings of apoptosis, anoikis, autophagy, necroptosis, ferroptosis, pyroptosis, and cuproptosis.
  • Integration of findings to identify therapeutic opportunities.

Main Results:

  • Cell death pathways are critically implicated in breast cancer development and progression.
  • Targeting specific cell death mechanisms presents promising therapeutic avenues.
  • Dysregulation of apoptosis and other cell death forms contributes to treatment resistance.

Conclusions:

  • Modulating cell death pathways offers a promising strategy for novel breast cancer therapies.
  • Further research into the intricate roles of diverse cell death types is warranted.
  • Translating mechanistic insights into clinical practice can enhance breast cancer management.

Related Concept Videos

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.9K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.7K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.3K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.8K
Cadherins in Tissue Organization01:19

Cadherins in Tissue Organization

The cadherins are a superfamily of cell adhesion molecules comprising over 180 variants, with specific tissues expressing a particular combination of cadherin types. Cadherins generally exhibit homophilic binding; i.e., cadherins on one cell bind to cadherins of the same or closely related type on another cell. Thus, cells of the same type have a specific affinity to bind to each other and sort themselves into clusters to form tissues.
Cell Sorting During Development
Cell sorting plays an...
3.8K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K